1. Reduction of the in vitro activity of A77003, an inhibitor of human immunodeficiency virus protease, by human serum a1-acid glycoprotein;Bilello;JID,1995
2. Phase I study of A77003, and HIV protease inhibitor, in man;Danner,1993
3. Phase I study of two formulations and dose schedules of SC-52151, a protease inhibitor;Fischl,1995
4. Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzyme;Kim;J. Am. Chem. Soc.,1995
5. Livingston, D.J., Pazhanisamy, S, Porter, D.J.T., Partaledis, J.A. and Painter, G. Investigation of the binding of VX-478 to human plasma proteins and implications for human anti-HIV therapy. JID (in press).